A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Completed · Not applicable
Conditions studied: Glucosephosphate Dehydrogenase Deficiency, Favism
In brief
This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.
Key facts
- Study ID
- NCT00076323
- Run by
- Walter Reed Army Institute of Research (WRAIR)
- People needed
- 14
- Starts
- 2003-12-01
- Expected to finish
- 2006-11-01
- Last updated by the study team
- 2010-07-27
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
Where it is running
- Walter Reed Army Institute of Research — Silver Spring, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.